Knowledge Graph Explorer
Discover and analyze research connections across medical domains
Filters
ENTITY TYPES
EVIDENCE STRENGTH
TIME PERIOD
FOCUS AREA
AI Research Assistant
LEGEND
Selected Entity
TreatmentTrastuzumab
Monoclonal antibody used to treat HER2-positive breast cancer by targeting the HER2 receptor.
CONNECTED TO
EVIDENCE STRENGTH
KEY SOURCES
First major trial demonstrating efficacy
Long-term cardiac safety data
Extended adjuvant therapy benefits
RESEARCH TRENDS
AI Analysis
Pattern identified: Trastuzumab shows strong connections to HER2+ breast cancer treatment pathways and moderate connections to several emerging biomarkers.
Research gap: Limited studies on potential effectiveness in HER2-low expressing cancers, which represents an opportunity area.
Emerging trend: Increasing research on combining trastuzumab with immune checkpoint inhibitors shows promising preliminary results.